Markets:

Overview

News

Currencies

International

Treasuries

Brainstorm Cell Therapeutics Inc. - Common Stock (NQ:BCLI)

1.170 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Brainstorm Cell Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights

October 27, 2025

From Halper Sadeh LLC

Via Business Wire

Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Brainstorm Cell Therapeutics Inc. (OTC: BCLI); Flywire Corporation (NASDAQ: FLYW); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf

September 22, 2025

From Grabar Law Office

Via GlobeNewswire

Brainstorm Posts 43% EPS Gain in Q2 ↗

August 14, 2025

Via The Motley Fool

Topics Intellectual Property

A Peek at Brainstorm Cell's Future Earnings ↗

August 13, 2025

Via Benzinga

A Preview Of Brainstorm Cell's Earnings ↗

March 28, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Friday? ↗

July 18, 2025

The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Brainstorm Cell Therapeutics Crashes 42% After Voluntary Nasdaq Delisting Announcement ↗

July 18, 2025

BrainStorm Cell Therapeutics Inc. shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced its voluntary delisting from the Nasdaq Capital Market.

Via Benzinga

BrainStorm Cell Therapeutics Crashes After Hours On Nasdaq Delisting Notice; Retail Sees 'Buy Time' ↗

July 18, 2025

The company plans to move its shares to the OTCQB market and says the delisting won't impact its ALS research or upcoming Phase 3b trial.

Via Stocktwits

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 17, 2025

Via Benzinga

Which stocks are moving after the closing bell on Thursday? ↗

July 17, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 21, 2025

Via Benzinga

These stocks have an unusual volume in today's session ↗

May 20, 2025

Which stocks have an unusual volume on Tuesday?

Via Chartmill

What's going on in today's pre-market session ↗

May 20, 2025

Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 20, 2025

Via Benzinga

Retail Bulls Cheer FDA Clearance For BrainStorm’s ALS Therapy, But Shares Dip After Hours ↗

May 19, 2025

BrainStorm Cell Therapeutics plans to enroll 200 ALS patients in its FDA-cleared Phase 3b trial of NurOwn, with a 24-week double-blind phase followed by an open-label extension.

Via Stocktwits

Topics Intellectual Property

Gapping stocks in Monday's session ↗

May 19, 2025

Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

These stocks are moving in today's pre-market session ↗

May 19, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 28, 2025

Via Benzinga

On Friday, there are stocks with unusual volume. Let's take a look. ↗

April 11, 2025

Unusual volume stocks in Friday's session

Via Chartmill

Earnings Scheduled For May 15, 2025 ↗

May 15, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 19, 2025

Via Benzinga

Earnings Scheduled For March 31, 2025 ↗

March 31, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 27, 2024

Via Benzinga

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

September 16, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

BCLI Stock Earnings: Brainstorm Cell Misses EPS for Q2 2024 ↗

August 14, 2024

BCLI stock results show that Brainstorm Cell missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.